Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVVD Invivyd, Inc.

休市中 04-02 16:00:00 EDT

1.28

-0.05

-3.76%

盘后1.34

+0.06+4.61%

19:59 EDT

最高1.34	最低1.26	成交量390.27万
今开1.31	昨收1.33	日振幅5.64%
总市值3.61亿	流通市值2.61亿	总股本2.82亿
成交额503.11万	换手率1.91%	流通股本2.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":1.28,"timestamp":1775160000000,"preClose":1.33,"halted":0,"volume":3902681,"hourTrading":{"tag":"盘后","latestPrice":1.339,"preClose":1.28,"latestTime":"19:59 EDT","volume":50461,"amount":65499.5372,"timestamp":1775174386226,"change":0.059,"changeRate":0.046094,"amplitude":0.046875},"delay":0,"changeRate":-0.03759398496240605,"floatShares":204000000,"shares":282000000,"eps":-0.304791,"marketStatus":"休市中","change":-0.05,"latestTime":"04-02 16:00:00 EDT","open":1.31,"high":1.335,"low":1.26,"amount":5031083.4514712,"amplitude":0.056391,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.304791,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":1.33,"preHourTrading":{"tag":"盘前","latestPrice":1.31,"preClose":1.33,"latestTime":"09:29 EDT","volume":7757,"amount":10236.9431523,"timestamp":1775136541058,"change":-0.02,"changeRate":-0.015038,"amplitude":0.030075},"postHourTrading":{"tag":"盘后","latestPrice":1.339,"preClose":1.28,"latestTime":"19:59 EDT","volume":50461,"amount":65499.5372,"timestamp":1775174386226,"change":0.059,"changeRate":0.046094,"amplitude":0.046875},"volumeRatio":1.1891275832133885,"impliedVol":1.1208,"impliedVolPercentile":0.4303},"requestUrl":"/m/hq/s/IVVD","defaultTab":"news","newsList":[{"id":"1110360648","title":"Invivyd公布2025年第四季度及全年财报，披露近期业务进展与Declaration临床试验更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1110360648","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110360648?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:05","pubTimestamp":1772712305,"startTime":"0","endTime":"0","summary":"Invivyd, Inc.近日发布了2025年第四季度及全年的财务业绩报告，同时公布了公司近期的业务发展动态以及Declaration临床试验项目的最新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609516039","title":"Invivyd, Inc.盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609516039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609516039?lang=zh_cn&edition=full","pubTime":"2026-02-07 01:54","pubTimestamp":1770400492,"startTime":"0","endTime":"0","summary":"北京时间2026年02月07日01时54分，Invivyd, Inc.股票出现波动，股价大幅下跌5.56%。截至发稿，该股报1.62美元/股，成交量350.453万股，换手率1.24%，振幅9.94%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207015452a4858f3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207015452a4858f3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198810666","title":"Invivyd与美国FDA就Liberty三期试验达成一致，将评估VYD2311抗体对比mRNA新冠疫苗安全性并探索抗体与疫苗联合使用的安全性与免疫学特征","url":"https://stock-news.laohu8.com/highlight/detail?id=1198810666","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198810666?lang=zh_cn&edition=full","pubTime":"2026-02-03 20:02","pubTimestamp":1770120135,"startTime":"0","endTime":"0","summary":"Invivyd公司已与美国食品药品监督管理局就Liberty三期临床试验方案达成共识。该试验旨在评估其研发的VYD2311抗体药物与mRNA新冠疫苗在安全性方面的对比数据，同时系统研究抗体与疫苗联合给药时的安全性和免疫学反应特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603866899","title":"Invivyd, Inc.盘中异动 早盘股价大跌5.10%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603866899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603866899?lang=zh_cn&edition=full","pubTime":"2026-01-14 00:25","pubTimestamp":1768321550,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日00时25分，Invivyd, Inc.股票出现异动，股价大幅下挫5.10%。截至发稿，该股报2.33美元/股，成交量109.826万股，换手率0.39%，振幅8.56%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114002550a4bf9ab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114002550a4bf9ab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601768888","title":"Invivyd, Inc.盘中异动 股价大跌5.10%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601768888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601768888?lang=zh_cn&edition=full","pubTime":"2026-01-07 01:42","pubTimestamp":1767721342,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日01时42分，Invivyd, Inc.股票出现波动，股价快速下挫5.10%。截至发稿，该股报2.42美元/股，成交量102.915万股，换手率0.37%，振幅6.47%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107014223a6fb3dea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107014223a6fb3dea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601421869","title":"Invivyd, Inc.盘中异动 早盘股价大跌5.20%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601421869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601421869?lang=zh_cn&edition=full","pubTime":"2026-01-05 23:34","pubTimestamp":1767627266,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日23时34分，Invivyd, Inc.股票出现异动，股价大幅跳水5.20%。截至发稿，该股报2.37美元/股，成交量86.8487万股，换手率0.31%，振幅6.80%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为1.88%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105233426953c056c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105233426953c056c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161114265","title":"Invivyd宣布启动Declaration临床试验，这是针对Vyd2311的第三阶段安慰剂对照关键研究，一种用于预防Covid的疫苗替代抗体","url":"https://stock-news.laohu8.com/highlight/detail?id=1161114265","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161114265?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:03","pubTimestamp":1766491396,"startTime":"0","endTime":"0","summary":"Invivyd宣布启动Declaration临床试验，这是针对Vyd2311的第三阶段安慰剂对照关键研究，一种用于预防Covid的疫苗替代抗体","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586089304","title":"Invivyd, Inc.盘中异动 急速跳水5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586089304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586089304?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:30","pubTimestamp":1764081051,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日22时30分，Invivyd, Inc.股票出现异动，股价大幅下挫5.42%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Pharmacyte  Biotech, Inc.、Anavex Life Sciences Corp.涨幅较大，Clearmind Medicine Inc.、Lunai Bioworks Inc.、Pasithea Therapeutics Corp.较为活跃，换手率分别为204.03%、126.16%、18.79%，振幅较大的相关个股有Pharmacyte  Biotech, Inc.、Anavex Life Sciences Corp.、Cardio Diagnostics Holdings Inc.，振幅分别为12.15%、7.95%、6.92%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223051a4b9b074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223051a4b9b074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134589274","title":"Invivyd宣布选定潜在的一流RSV抗体候选药物Vby329；目标为2026年下半年IND准备就绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1134589274","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134589274?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:02","pubTimestamp":1763985764,"startTime":"0","endTime":"0","summary":"Invivyd宣布选定潜在的一流RSV抗体候选药物Vby329；目标为2026年下半年IND准备就绪","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191384298","title":"Invivyd 第三季度每股收益为 -0.06 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191384298","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191384298?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:57","pubTimestamp":1763571449,"startTime":"0","endTime":"0","summary":"11月6日 - Invivyd 第三季度收入为 1312.9 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172620322","title":"Invivyd第三季度每股收益为-0.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172620322","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172620322?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:16","pubTimestamp":1762431395,"startTime":"0","endTime":"0","summary":"11月6日 - Invivyd第三季度营收为1312.9万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117108328","title":"Invivyd宣布获得美国IND批准，并与美国FDA就预防新冠疫苗替代抗体Vyd2311的关键临床项目达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1117108328","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117108328?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:03","pubTimestamp":1759748601,"startTime":"0","endTime":"0","summary":"Invivyd宣布获得美国IND批准，并与美国FDA就预防新冠疫苗替代抗体Vyd2311的关键临床项目达成一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148205802","title":"Invivyd Inc：Declaration和Liberty临床试验预计2025年底启动，主要数据预期2026年中期公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1148205802","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148205802?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:03","pubTimestamp":1759748588,"startTime":"0","endTime":"0","summary":"Invivyd Inc宣布，公司的Declaration和Liberty临床试验计划在2025年底前后开始进行。该公司预计相关试验的主要临床数据将在2026年中期对外公布。\n这两项临床试验的启动标志着Invivyd Inc在其研发管线推进方面的重要里程碑，市场将密切关注试验进展及后续数据发布情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518271809","title":"Invivyd, Inc.盘中异动 早盘快速跳水5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518271809?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:09","pubTimestamp":1741619349,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时09分，Invivyd, Inc.股票出现波动，股价大幅下挫5.59%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3551.71%、926.79%、795.06%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230909a26a4960&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230909a26a4960&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517161369","title":"Invivyd, Inc.盘中异动 快速跳水5.86%报0.998美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161369?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:00","pubTimestamp":1741273241,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时00分，Invivyd, Inc.股票出现波动，股价快速跳水5.86%。截至发稿，该股报0.998美元/股，成交量26.2609万股，换手率0.22%，振幅2.83%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230042963c5360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230042963c5360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948823","title":"Invivyd, Inc.盘中异动 股价大涨6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948823?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:36","pubTimestamp":1741185399,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时36分，Invivyd, Inc.股票出现异动，股价大幅拉升6.67%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为390.41%、261.05%、190.80%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Invivyd, Inc.，振幅分别为23.90%、20.71%、13.32%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223639963add94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223639963add94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516305677","title":"Invivyd, Inc.盘中异动 早盘急速跳水9.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516305677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516305677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098916,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分，Invivyd, Inc.股票出现异动，股价大幅跳水9.11%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1076.47%、1070.68%、423.99%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.，振幅分别为23.30%、12.57%、12.01%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223516989bad0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223516989bad0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514332074","title":"Invivyd, Inc.盘中异动 早盘股价大跌7.21%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332074?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753116,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Invivyd, Inc.股票出现异动，股价大幅跳水7.21%。截至发稿，该股报1.15美元/股，成交量11.3726万股，换手率0.10%，振幅1.60%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514338978","title":"Invivyd, Inc.盘中异动 大幅拉升5.28%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514338978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514338978?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:11","pubTimestamp":1740669110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时11分，Invivyd, Inc.股票出现波动，股价快速上涨5.28%。截至发稿，该股报1.30美元/股，成交量44.3116万股，换手率0.37%，振幅8.13%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231150989518cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231150989518cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856912","title":"Invivyd, Inc.盘中异动 股价大跌5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856912?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:36","pubTimestamp":1740580583,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时36分，Invivyd, Inc.股票出现异动，股价快速下跌5.77%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262236239631501b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262236239631501b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.invivyd.com","stockEarnings":[{"period":"1week","weight":-0.1523},{"period":"1month","weight":-0.2099},{"period":"3month","weight":-0.488},{"period":"6month","weight":0.1034},{"period":"1year","weight":1.2103},{"period":"ytd","weight":-0.4818}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Invivyd, Inc.于2020年6月3日在特拉华州成立。该公司是一家处于商业阶段的公司，其使命是快速、永久地提供基于抗体的疗法，以保护脆弱人群免受流行病毒威胁的破坏性后果，从SARS-CoV-2开始。该公司专有的INVYMAB平台方法将最先进的病毒监测和预测建模与先进的抗体工程相结合。INVYMAB旨在促进快速、连续产生新的单克隆抗体（“MAB”），以跟上不断演变的病毒威胁。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.046272},{"month":2,"riseRate":0.2,"avgChangeRate":0.346603},{"month":3,"riseRate":0.2,"avgChangeRate":-0.241584},{"month":4,"riseRate":0.2,"avgChangeRate":-0.186078},{"month":5,"riseRate":0.75,"avgChangeRate":0.245954},{"month":6,"riseRate":0.25,"avgChangeRate":-0.236507},{"month":7,"riseRate":0.75,"avgChangeRate":0.147422},{"month":8,"riseRate":0.75,"avgChangeRate":0.158597},{"month":9,"riseRate":0.6,"avgChangeRate":0.03577},{"month":10,"riseRate":0.4,"avgChangeRate":0.071726},{"month":11,"riseRate":0.4,"avgChangeRate":0.062538},{"month":12,"riseRate":0.4,"avgChangeRate":0.008789}],"exchange":"NASDAQ","name":"Invivyd, Inc.","nameEN":"Invivyd, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Invivyd, Inc.,IVVD,Invivyd, Inc.股票,Invivyd, Inc.股票老虎,Invivyd, Inc.股票老虎国际,Invivyd, Inc.行情,Invivyd, Inc.股票行情,Invivyd, Inc.股价,Invivyd, Inc.股市,Invivyd, Inc.股票价格,Invivyd, Inc.股票交易,Invivyd, Inc.股票购买,Invivyd, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}